Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Engineered CD4 T cells for in vivo delivery of therapeutic proteins

Proceedings of the National Academy of Sciences(2024)10.1073/pnas.2318687121Source: DataRank Database

Engineered CD4 T cells for in vivo delivery of therapeutic proteins is a research paper published in Proceedings of the National Academy of Sciences (2024). On theSindex it has a DataRank of 0.292. It has been cited 6 times.

N/A

0.292DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 1.05)OA: hybridTopics (34)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.292

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (4)

Sherri L. Newmyer ORCID,Harold S. Javitz ORCID,Parijat Bhatnagar ORCID,Harikrishnan Radhakrishnan ORCID

Live enrichment

PubMed:39312667 PMC:PMC11459198 OpenAlex:https://openalex.org/W4402741251

HHS | NIH | OSC | Common Fund

Grant: DP2EB024245

HHS | NIH | National Cancer Institute

Grant: R21CA236640

HHS | NIH | National Cancer Institute

Grant: R33CA247739

HHS | NIH | National Cancer Institute

Grant: R21CA288900

HHS | NIH | National Cancer Institute

Grant: R61CA281785

DOD | Defense Advanced Research Projects Agency

Grant: D19AP00024

FWCI

1.05

Citation Percentile

0.8%

Citation Trend

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://www.pnas.org/doi/pdf/10.1073/pnas.2318687121

publisherhttps://www.pnas.org/doi/pdf/10.1073/pnas.2318687121

publisherhttps://pnas.org/doi/pdf/10.1073/pnas.2318687121

journalhttps://doi.org/10.1073/pnas.2318687121

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39312667

Fields of Study

CAR-T cell therapy researchVirus-based gene therapy researchViral Infectious Diseases and Gene Expression in InsectsCD4-Positive T-LymphocytesAnimalsHumansReceptors, Chimeric AntigenMiceCD8-Positive T-LymphocytesDrug Delivery SystemsCD28 AntigensCell Line, TumorProtein Engineering

MeSH Terms

Receptors, Chimeric AntigenAnimalsHumansProtein EngineeringCD4-Positive T-LymphocytesDrug Delivery SystemsCD28 AntigensCD8-Positive T-LymphocytesCell Line, TumorMice

Keywords

In vivoCell biologyChemistryComputational biologyBiologyBiotechnologyT Cell EngineeringCell-based Drug DeliveryT Cell ManufacturingCd4 Car T CellsNuclear Factor Of The Activated T Cell Response Element

Engineered CD4 T cells for in vivo delivery of therapeutic proteins

FAIR Checklist

DataRank Breakdown

Authors (4)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)